InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Stuart Iain, Directeur Scientifique. Officer active across 1 company, notably VYNE Therapeutics Inc.. Aggregated, 23 disclosures have been published. Activity tracked since 30 June 2021. The latest transaction was disclosed on 31 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations23 total
6,044 shares@ US$1.5815.0% of flowCommon StockSEC:0001415889-25-009632:0
4,857 shares@ US$3.3526.5% of flowCommon StockSEC:0001415889-25-000155:0
109 shares@ US$1.880.3% of flowCommon StockSEC:0001415889-24-024382:0
138 shares@ US$1.920.4% of flowCommon StockSEC:0001415889-24-019175:0
157 shares@ US$3.080.8% of flowCommon StockSEC:0001415889-24-010070:0
62,500 shares0Common StockSEC:0001209191-24-000469:0
62,500 shares0Common StockSEC:0001209191-23-058818:0
1,184 shares@ US$3.837.3% of flowCommon StockSEC:0001209191-23-051948:0
151 shares@ US$4.101.0% of flowCommon StockSEC:0001209191-23-041120:0
480 shares@ US$3.082.3% of flowCommon StockSEC:0001209191-23-022801:0
1,720 shares@ US$0.150.4% of flowCommon StockSEC:0001209191-23-001098:0
1,719 shares@ US$0.2230.7% of flowCommon StockSEC:0001209191-22-052356:0
1,719 shares@ US$0.3891.1% of flowCommon StockSEC:0001209191-22-040788:0
3,469 shares@ US$0.650.011% mcap7.8% of flowCommon StockSEC:0001209191-22-022530:0
75,000 shares0Common StockSEC:0001209191-22-020066:0
1,250 shares@ US$1.021.9% of flowCommon StockSEC:0001209191-22-000858
1,250 shares@ US$1.020.0058% mcap4.3% of flowCommon StockSEC:0001209191-22-000858:0
1,480 shares@ US$1.390.0092% mcap6.8% of flowCommon StockSEC:0001209191-21-058519:0
1,480 shares@ US$1.393.0% of flowCommon StockSEC:0001209191-21-058519
60,859 shares0Common StockSEC:0001209191-21-054836
60,859 shares0Common StockSEC:0001209191-21-054836:0
3,083 shares@ US$3.5115.5% of flowCommon StockSEC:0001209191-21-044979
3,083 shares@ US$3.510.047% mcap35.0% of flowCommon StockSEC:0001209191-21-044979:0
23 of 23 declarations
About Stuart Iain
Iain Stuart is the Chief Scientific Officer at VYNE Therapeutics Inc. In this role, he is responsible for leading the company's scientific and research initiatives. Stuart brings valuable expertise in biotechnology and drug development, contributing to innovation in healthcare. His commitment to improving treatments and patient care is essential in guiding VYNE's projects. He collaborates with research teams to ensure the success of clinical trials and the development of new treatments.
